Exact Mass: 648.4965

Exact Mass Matches: 648.4965

Found 54 metabolites which its exact mass value is equals to given mass value 648.4965, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Uvaricin

SCHEMBL5881205

C39H68O7 (648.4965)


   

DG(16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-(Hexadecanoyloxy)-3-hydroxypropan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C39H68O7 (648.4965)


DG(16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/16:0/0:0)

(2S)-2-(hexadecanoyloxy)-3-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C39H68O7 (648.4965)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-3-(hexadecanoyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C39H68O7 (648.4965)


DG(16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/16:0)

(2S)-3-(Hexadecanoyloxy)-2-hydroxypropyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-(Hexadecanoyloxy)-3-hydroxypropan-2-yl (5S,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/16:0/0:0)

(2S)-2-(Hexadecanoyloxy)-3-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-3-(Hexadecanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/16:0)

(2S)-3-(Hexadecanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-(Hexadecanoyloxy)-3-hydroxypropan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C39H68O7 (648.4965)


DG(16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/16:0/0:0)

(2S)-2-(Hexadecanoyloxy)-3-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-3-(Hexadecanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C39H68O7 (648.4965)


DG(16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/16:0)

(2S)-3-(Hexadecanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propan-2-yl (5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C39H68O7 (648.4965)


DG(i-16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-16:0/0:0)

(2S)-3-Hydroxy-2-[(14-methylpentadecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C39H68O7 (648.4965)


DG(i-16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-16:0)

(2S)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propan-2-yl (5S,6E,8Z,11Z,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(i-16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-16:0/0:0)

(2S)-3-hydroxy-2-[(14-methylpentadecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C39H68O7 (648.4965)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(i-16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-16:0)

(2S)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-hydroxy-3-[(14-methylpentadecanoyl)oxy]propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C39H68O7 (648.4965)


DG(i-16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-16:0/0:0)

(2S)-3-hydroxy-2-[(14-methylpentadecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C39H68O7 (648.4965)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C39H68O7 (648.4965)


DG(i-16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-16:0)

(2S)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

1,3-divernolin

1,3-divernolin

C39H68O7 (648.4965)


   

solamin diacetate

solamin diacetate

C39H68O7 (648.4965)


   

DG(16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C39H68O7 (648.4965)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/16:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/16:0/0:0)

C39H68O7 (648.4965)


   

DG(16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C39H68O7 (648.4965)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/16:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/16:0)

C39H68O7 (648.4965)


   

DG(16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C39H68O7 (648.4965)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/16:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/16:0/0:0)

C39H68O7 (648.4965)


   

DG(16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C39H68O7 (648.4965)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/16:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/16:0)

C39H68O7 (648.4965)


   

DG(16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C39H68O7 (648.4965)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/16:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/16:0/0:0)

C39H68O7 (648.4965)


   

DG(16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C39H68O7 (648.4965)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/16:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/16:0)

C39H68O7 (648.4965)


   

DG(i-16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(i-16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C39H68O7 (648.4965)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-16:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-16:0/0:0)

C39H68O7 (648.4965)


   

DG(i-16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(i-16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C39H68O7 (648.4965)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-16:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-16:0)

C39H68O7 (648.4965)


   

DG(i-16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(i-16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C39H68O7 (648.4965)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-16:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-16:0/0:0)

C39H68O7 (648.4965)


   

DG(i-16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(i-16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C39H68O7 (648.4965)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-16:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-16:0)

C39H68O7 (648.4965)


   

DG(i-16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(i-16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C39H68O7 (648.4965)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-16:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-16:0/0:0)

C39H68O7 (648.4965)


   

DG(i-16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(i-16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C39H68O7 (648.4965)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-16:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-16:0)

C39H68O7 (648.4965)


   

1-{5-[1-(acetyloxy)tridecyl]oxolan-2-yl}-13-(5-methyl-2-oxo-5h-furan-3-yl)tridecyl acetate

1-{5-[1-(acetyloxy)tridecyl]oxolan-2-yl}-13-(5-methyl-2-oxo-5h-furan-3-yl)tridecyl acetate

C39H68O7 (648.4965)


   

(1s)-1-[(2'r,5r)-5'-[(1r)-1-hydroxy-13-[(5s)-5-methyl-2-oxo-5h-furan-3-yl]tridecyl]-[2,2'-bioxolan]-5-yl]undecyl acetate

(1s)-1-[(2'r,5r)-5'-[(1r)-1-hydroxy-13-[(5s)-5-methyl-2-oxo-5h-furan-3-yl]tridecyl]-[2,2'-bioxolan]-5-yl]undecyl acetate

C39H68O7 (648.4965)


   

(1s)-1-[(2r,5s)-5-[(1s)-1-(acetyloxy)tridecyl]oxolan-2-yl]-13-[(5r)-5-methyl-2-oxo-5h-furan-3-yl]tridecyl acetate

(1s)-1-[(2r,5s)-5-[(1s)-1-(acetyloxy)tridecyl]oxolan-2-yl]-13-[(5r)-5-methyl-2-oxo-5h-furan-3-yl]tridecyl acetate

C39H68O7 (648.4965)